KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Moderna (MRNA) Leases (2018 - 2025)

Moderna (MRNA) has disclosed Leases for 8 consecutive years, with $719.0 million as the latest value for Q4 2025.

  • Quarterly Leases fell 5.27% to $719.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $719.0 million through Dec 2025, down 5.27% year-over-year, with the annual reading at $719.0 million for FY2025, 5.27% down from the prior year.
  • Leases for Q4 2025 was $719.0 million at Moderna, down from $738.0 million in the prior quarter.
  • The five-year high for Leases was $1.2 billion in Q3 2022, with the low at $99.0 million in Q1 2021.
  • Average Leases over 5 years is $736.2 million, with a median of $728.5 million recorded in 2025.
  • The sharpest move saw Leases surged 638.89% in 2021, then plummeted 50.29% in 2023.
  • Over 5 years, Leases stood at $665.0 million in 2021, then skyrocketed by 72.93% to $1.2 billion in 2022, then crashed by 38.0% to $713.0 million in 2023, then rose by 6.45% to $759.0 million in 2024, then dropped by 5.27% to $719.0 million in 2025.
  • According to Business Quant data, Leases over the past three periods came in at $719.0 million, $738.0 million, and $750.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.